The levels of the antioxidant enzymes and trace elements in patients with chronic viral hepatitis and alcoholic liver disease
Sayal, A; Erçin, N; Erdil, A; Kartal, Y; Kayaaltı, Z
Toxicology Letters 221: S77-S78
2013
ISSN/ISBN: 0378-4274
DOI: 10.1016/j.toxlet.2013.05.073
Accession: 064404748
PDF emailed within 0-6 h: $19.90
Related References
Van Iderstine, M.G.; Uhanova, J.; Minuk, G.Y. 2021: Liver enzymes and fibrosis markers in patients with non-alcoholic fatty liver disease and concomitant chronic viral hepatitis Canadian Liver Journal 4(3): 317-321Ravagnan, P.; Lorenzoni, U.; Galliani, E.A.; Tenderini, M.L.; Popovic, A.; Floreani, A.; Vicariotto, M.A.; Donadel, C.; De Lazzari, F. 1998: Serum levels of soluble CD30 in chronic viral hepatitis and alcoholic liver disease Gastroenterology 114(4 Part 2): A1327
Golabi, P.; Paik, J.M.; Eberly, K.; de Avila, L.; Alqahtani, S.A.; Younossi, Z.M. 2022: Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C Annals of Hepatology 27(1): 100556
Evans, C.; Robertson, S.; Gracie, A.; Mcinnes, I.; Morris, J. 2002: Plasma interleukin-18 levels in chronic alcoholic liver disease and alcoholic hepatitis are related to disease severity Hepatology 36(4 Part 2): 727A
Ong Ajyooth, L.; Ong Ajyooth, S.; Likidlilid, A.; Chantachum, Y.; Shayakul, C.; Nilwarangkur, S. 1995: Lipid peroxidation, trace elements and antioxidant enzymes in chronic renal disease patients Nephrology Dialysis Transplantation 10(6): 988
Naito, M.; Hayashi, N.; Moribe, T.; Hagiwara, H.; Mita, E.; Kanazawa, Y.; Kasahara, A.; Fusamoto, H.; Kamada, T. 1995: Hepatitis C Viral Quasispecies in Hepatitis C Virus Carriers With Normal Liver Enzymes and Patients With Type C Chronic Liver Disease Hepatology 22(2): 407-412
Ongajooth, L.; Ongajyooth, S.; Likidlilid, A.; Chantachum, Y.; Shayakul, C.; Nilwarangkur, S. 1996: Role of lipid peroxidation, trace elements and antioxidant enzymes in chronic renal disease patients Chot Mai het Thang Phaet 79(12): 791-800
Sekamova, S.M.; Serov, V.V.; Tanashchuk, E.L.; Popova, I.V.; Iusov, S.P. 1998: Electron microscopic study of the liver in chronic viral hepatitis C complicated by alcoholic liver disease Arkhiv Patologii 60(5): 52-58
Gerli, G.; Locatelli, G.F.; Mongiat, R.; Zenoni, L.; Agostoni, A.; Moschini, G.; Zafiropoulos, D.; Bruno, S.; Rossi, S.; Vignati, A. 1992: Erythrocyte antioxidant activity, serum ceruloplasmin, and trace element levels in subjects with alcoholic liver disease American Journal of Clinical Pathology 97(5): 614-618
Pár, A.; Róth, E.; Rumi, G.; Kovács, Z.; Nemes, J.; Mózsik, G. 2000: Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C Orvosi Hetilap 141(30): 1655-1659
Naito, M.; Hayashi, N.; Moribe, T.; Hagiwara, H.; Mita, E.; Kanazawa, Y.; Kasahara, A.; Fusamoto, H.; Kamada, T. 1995: Hepatitis C viral quasispecies in hepatitis C virus carriers with normal enzymes and patients with type C chronic liver disease Hepatology (Baltimore, Md.) 22(2): 407-412
Lee, S.H.; Jeong, S.-H.; Park, Y.S.; Hwang, J.-H.; Kim, J.-W.; Kim, N.; Lee, D.H. 2010: Serum prohepcidin levels in chronic hepatitis C, alcoholic liver disease, and nonalcoholic fatty liver disease Korean Journal of Hepatology 16(3): 288-294
Sarin, S.K.; Guptan, R.C.; Banerjee, K.; Khandekar, P. 1996: Low prevalence of hepatitis C viral infection in patients with non-alcoholic chronic liver disease in India Journal of the Association of Physicians of India 44(4): 243-245
George, M.; Van Thiel, D.; Hoppensteadt, D.; Amiral, J.; Fareed, J. 1999: Circulating levels of P and E sh-Selectins but not sh- L-Selectin differ between individuals with chronic advanced alcoholic versus chronic viral liver disease Hepatology 30(4 Part 2): 591A
Van de Casteele, M.; Zaman, Z.; Zeegers, M.; Servaes, R.; Fevery, J.; Nevens, F. 2002: Blood antioxidant levels in patients with alcoholic liver disease correlate with the degree of liver impairment and are not specific to alcoholic liver injury itself Alimentary Pharmacology and Therapeutics 16(5): 985-992